625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors
Publication
, Conference
Hwang, J; Dzimitrowicz, H; Shah, R; Ashcraft, K; George, D; Salama, A; Zhang, T
Published in: Journal for ImmunoTherapy of Cancer
November 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal for ImmunoTherapy of Cancer
DOI
EISSN
2051-1426
Publication Date
November 2021
Volume
9
Issue
Suppl 2
Start / End Page
A655 / A655
Publisher
BMJ
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hwang, J., Dzimitrowicz, H., Shah, R., Ashcraft, K., George, D., Salama, A., & Zhang, T. (2021). 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. In Journal for ImmunoTherapy of Cancer (Vol. 9, pp. A655–A655). BMJ. https://doi.org/10.1136/jitc-2021-sitc2021.625
Hwang, Joyce, Hannah Dzimitrowicz, Riddhishkumar Shah, Kathleen Ashcraft, Daniel George, April Salama, and Tian Zhang. “625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors.” In Journal for ImmunoTherapy of Cancer, 9:A655–A655. BMJ, 2021. https://doi.org/10.1136/jitc-2021-sitc2021.625.
Hwang J, Dzimitrowicz H, Shah R, Ashcraft K, George D, Salama A, et al. 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. In: Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A655–A655.
Hwang, Joyce, et al. “625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors.” Journal for ImmunoTherapy of Cancer, vol. 9, no. Suppl 2, BMJ, 2021, pp. A655–A655. Crossref, doi:10.1136/jitc-2021-sitc2021.625.
Hwang J, Dzimitrowicz H, Shah R, Ashcraft K, George D, Salama A, Zhang T. 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. A655–A655.
Published In
Journal for ImmunoTherapy of Cancer
DOI
EISSN
2051-1426
Publication Date
November 2021
Volume
9
Issue
Suppl 2
Start / End Page
A655 / A655
Publisher
BMJ
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology